{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:58:56Z","timestamp":1793213936362,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["3101-00102B"],"award-info":[{"award-number":["3101-00102B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lanepe.2023.100739","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:07:49Z","timestamp":1695906469000},"page":"100739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-7040","authenticated-orcid":false,"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry R.","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-2212","authenticated-orcid":false,"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2023.100739_bib1","first-page":"188","article-title":"De l\u2019obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general","volume":"1","author":"Bouillaud","year":"1823","journal-title":"Arch Gen Med"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100739_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100739_bib3","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","article-title":"Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study","volume":"123","author":"Chee","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100739_bib4","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100739_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"Weitz","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100739_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100739_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2023.100739_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2016.07.013","article-title":"Evaluation of US prescription patterns: are treatment guidelines for cancer-associated venous thromboembolism being followed?","volume":"145","author":"Khorana","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100739_bib9","first-page":"493","article-title":"Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The recovery study","volume":"108","author":"Kahn","year":"2012","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100739_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100739_bib11","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100739_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjmed.2021.01.031","article-title":"Increasing incidence and declining mortality after cancer-associated venous thromboembolism: a nationwide cohort study","volume":"134","author":"Ording","year":"2021","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100739_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"issue":"9162","key":"10.1016\/j.lanepe.2023.100739_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100739_bib15","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/bloodadvances.2022009577","article-title":"Survival after cancer-related venous thrombosis: the Scandinavian thrombosis and cancer study","volume":"7","author":"Crobach","year":"2023","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100739_bib16","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMra1712502","article-title":"Cancer survivorship","volume":"379","author":"Shapiro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9974","key":"10.1016\/j.lanepe.2023.100739_bib17","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(14)61396-9","article-title":"40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study","volume":"385","author":"Quaresma","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2023.100739_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100739_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaccao.2021.02.007","article-title":"Arterial thromboembolism in cancer patients: a Danish population-based cohort study","volume":"3","author":"Mulder","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"10132","key":"10.1016\/j.lanepe.2023.100739_bib20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2023.100739_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson Comorbidity Index conditions in the population-based Danish national registry of patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100739_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100739_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100739_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/jth.15250","article-title":"Pulmonary embolism at autopsy in cancer patients","volume":"19","author":"Gimbel","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100739_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01697-2019","article-title":"Clinical implications of incidental venous thromboembolism in cancer patients","volume":"55","author":"Mulder","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100739_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/M21-2981","article-title":"Risk for recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation: a multicenter prospective cohort study","volume":"175","author":"Le Gal","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100739_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","article-title":"Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?","volume":"20","author":"Ward","year":"2021","journal-title":"Mol Cancer"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100739_bib28","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/jth.15880","article-title":"Hemostasis and cancer: impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer","volume":"20","author":"Moik","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100739_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100739_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12744","article-title":"Thrombotic complications in patients with cancer: advances in pathogenesis, prevention, and treatment-a report from ICTHIC 2021","volume":"6","author":"Falanga","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"16","key":"10.1016\/j.lanepe.2023.100739_bib31","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100739_bib32","first-page":"1181","article-title":"Cancer-associated venous thromboembolic disease, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Streiff","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100739_bib33","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.lanepe.2023.100739_bib34","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2020003115","article-title":"Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis","volume":"4","author":"Bosch","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100739_bib35","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1016\/S2352-3026(20)30293-3","article-title":"Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis","volume":"7","author":"Sch\u00fcnemann","year":"2020","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100739_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish national patient registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100739_bib37","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Pottegard","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanepe.2023.100739_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100739_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ije\/17.1.44","article-title":"Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures","volume":"17","author":"Storm","year":"1988","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100739_bib40","first-page":"535","article-title":"The Danish cancer registry--history, content, quality and use","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776223001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:56:36Z","timestamp":1763009796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776223001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"alternative-id":["S2666776223001588"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100739","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100739"}}